Abstract
Primary care physicians are in a favorable position to curb the growing burden of
pancreatic ductal adenocarcinoma. This review aims to provide an overview of pancreatic
ductal adenocarcinoma from a primary care perspective, with a specific focus on risk
factors, selection of high-risk individuals for screening, patient presentation at
the primary-care clinic, and the role of the internist in supportive care. Overall,
the internist is an essential member of the multidisciplinary care team with respect
to optimizing patients’ quality of life across various stages of the pancreatic cancer.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2020.CA Cancer J Clin. 2020; 70: 7-30
- Epidemiology of pancreatic cancer: global trends, etiology and risk factors.World J Oncol. 2019; 10: 10-27
- The association between dietary zinc intake and risk of pancreatic cancer: a meta-analysis.Biosci Rep. 2017; 37BSR20170155
- Folate intake and the risk of upper gastrointestinal cancers: a systematic review and meta-analysis.J Gastroenterol Hepatol. 2014; 29: 250-258
- Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.Eur J Epidemiol. 2015; 30: 279-298
- Statin use and risk of pancreatic cancer: an updated meta-analysis of 26 studies.Pancreas. 2019; 48: 142-150
- Incretin-based therapies and risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.Diabetes Obes Metab. 2018; 20: 910-920
- Diabetes mellitus and risk of pancreatic cancer in China: a meta-analysis based on 26 case-control studies.Prim Care Diabetes. 2019; 13: 276-282
- Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis.Am J Gastroenterol. 2017; 112: 1366-1372
- Dietary patterns and pancreatic cancer risk: a meta-analysis.Nutrients. 2017; 9: 38
- Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: a comprehensive review and meta-analysis.Eur J Cancer. 2018; 104: 117-126
- Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies.Clin Gastroenterol Hepatol. 2014; 12: 1635-1644
- Dietary fiber intake is inversely associated with risk of pancreatic cancer: a meta-analysis.Asia Pac J Clin Nutr. 2017; 26: 89-96
- Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis.Int J Food Sci Nutr. 2016; 67: 744-753
- Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies.Br J Cancer. 2012; 106: 603-607
- Association of cholesterol with risk of pancreatic cancer: a meta-analysis.World J Gastroenterol. 2015; 21: 3711-3719
- Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis.BMJ. 2015; 350: g7371
- Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk.Nutr Rev. 2017; 75: 405-419
- Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.Fam Cancer. 2009; 8: 109-117
- Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.Cancer Res. 2004; 64: 2634-2638
- Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes.World J Gastroenterol. 2018; 24: 4846-4861
- Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection.Clin Cancer Res. 2020; 26: 3239-3247
- Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.Am J Surg Pathol. 2006; 30: 1067-1076
- Pancreatic cancer: pathogenesis, prevention and treatment.Toxicol Appl Pharmacol. 2007; 224: 326-336
National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Cancer stat facts: pancreatic cancer 2020. Available at: https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed July 23, 2020.
- Screening for pancreatic cancer gets a D, but the student is improving.JAMA Surg. 2019; 154: 795-797
- Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.Gut. 2015; 64: 1783-1789
- Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion.J Clin Oncol. 2019; 37: 153-164
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.Gut. 2020; 69: 7-17
- Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.Gastroenterology. 2012; 142: 796-804
- Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds.Gastrointest Endosc. 2007; 66: 62-67
- A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.BMJ Open. 2014; 4e005720
- Symptoms of pancreatic cancer in primary care: a systematic review.Pancreas. 2016; 45: 814-818
- The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records.Br J Cancer. 2012; 106: 1940-1944
- Molecular imaging in pancreatic cancer–a roadmap for therapeutic decisions.Cancer Lett. 2013; 341: 132-138
- Magnetic resonance imaging of adenocarcinoma of the pancreas.Top Magn Reson Imaging. 2009; 20: 3-9
- Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.Am J Clin Oncol. 2010; 33: 257-261
- The role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma.Abdom Radiol (NY). 2018; 43: 415-434
- Prognostic and predictive factors in pancreatic cancer.Oncotarget. 2020; 11: 924-941
- Surgical resectability of pancreatic adenocarcinoma: CTA.Abdom Imaging. 2010; 35: 471-480
- Going the extra mile: improved survival for pancreatic cancer patients traveling to high-volume centers.Ann Surg. 2017; 266: 333-338
- Upfront surgery versus neoadjuvant therapy for resectable pancreatic cancer: systematic review and Bayesian network meta-analysis.Sci Rep. 2019; 9: 4354
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.Lancet. 2017; 389: 1011-1024
- Unicancer GI PRODIGE 24/CCTG PA.6 trial: a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.J Clin Oncol. 2018; 36 (LBA4001-LBA)
- New-onset diabetes after pancreatoduodenectomy: a systematic review and meta-analysis.Surgery. 2018; S0039-6060: 30081-30083
- Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol. 2020; 21: 242-249
- Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.JAMA. 2013; 309: 1359-1367
- The effect of duloxetine on chemotherapy-induced peripheral neuropathy in advanced pancreatic cancer patients receiving gemcitabine plus nab-paclitaxel treatment.J Clin Oncol. 2017; 35: 453
- A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.Ther Adv Med Oncol. 2017; 9: 75-82
Article Info
Publication History
Published online: December 11, 2020
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: All authors had access to data and contributed to the drafting of this manuscript.
Identification
Copyright
© 2021 Published by Elsevier Inc.
